SCR-LIP-000302 · Claim · machine-readable JSON →

This narrative review synthesizes lipedema pathophysiology as a self-perpetuating cycle of adipocyte hypertrophy, dense interstitial fibrosis, lymphatic microangiopathy, and chronic low-grade inflammation, with M1 macrophage accumulation secreting TNF-alpha, IL-6, and MCP-1 and elevated fibrotic marker YKL-40, plus estrogen-axis dysregulation (ERbeta predominance, local estradiol excess) and mitochondrial dysfunction (reduced oxidative capacity, UCP1 downregulation).

Claim at a glance

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

Tirzepatide as a Potential Disease-Modifying Therapy in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, and Fibrosis — Viana et al. (2025) ✓ verified — consistent · review · 2025 · reading confidence: high
“inflamação crônica de baixo grau, com acúmulo de macrófagos M1 secretando TNF-alfa, IL-6 e MCP-1, e marcador fibrótico YKL-40 elevado”
The article is a narrative review describing inflammatory mechanisms in lipedema tissue, including M1 macrophage polarization and pro-inflammatory cytokines, which directly addresses the inflammation mechanism aspect of the question; howeve

Populationwomen with lipedema

Conditionlipedema

Exposureadipocyte hypertrophy, fibrosis, lymphatic dysfunction, inflammation

Outcomeintegrated pathophysiological mechanisms of lipedema

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.